Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 141 No. 2728 (2011)

MRSA admission screening in a low prevalence setting – much ado about nothing?

  • G Rettenmund
  • M Schlegel
Cite this as:
Swiss Med Wkly. 2011;141:w13217


OBJECTIVE: To prospectively evaluate new guidelines for MRSA admission screening and pre-emptive isolation implemented in response to a doubling of newly diagnosed MRSA patients in 2007.

DESIGN: One-year surveillance (04/2008–03/2009).

SETTING: Patients admitted to the tertiary-care hospital in St. Gallen (700 beds) and 10 affiliated public hospitals (890 beds) in Eastern Switzerland (MRSA rate 2.5% in isolates).

PATIENTS: Except for known MRSA carriers, all patients who underwent admission screening in accordance with the guidelines and all MRSA patients newly detected by a clinical sample were included.

METHODS: Depending on epidemiological factors (stay in a foreign hospital, a Swiss hospital with known high MRSA prevalence, or a chronic care facility) and personal risk factors (wound, tracheostoma, urinary catheter, IVDU), patients were risk stratified into screening and isolation, only screening or no screening at all. MRSA admission screening included nasal, throat and axillary/inguinal swabs, supplemented by wound swabs, urine and respiratory secretion whenever appropriate (conventional culture).

RESULTS:A total of6/161 (3.7%) MRSA admission screenings yielded positive results (number needed to screen: 27). 2/32 (6.3%) pre-emptively isolated patients were positive (number needed to isolate: 16). Only 6/27 (22.2%) newly diagnosed MRSA patients were detected by admission screening, and the remaining patients were detected by clinical sample during hospitalisation. A total of 80% of the MRSA positive patients had wounds. Swabs of axilla/inguina did not increase the sensitivity of the admission screening.

CONCLUSIONS:In the setting of low MRSA prevalence, admission screening of patients at high risk for MRSA carriage detected only one out of five newly diagnosed MRSA patients, emphasising the importance of standard precautions for the prevention of MRSA transmission.


  1. Diekema DJ, Pfaller Ma, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M; SENTRY Participants Group. Survey of infections due to Staphylococcus species: frequency of occurence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin Amercia, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis. 2001;32(Suppl 2):S114–132.
  2. Gould IM. The clinical significance of methicillin-resistant Staphylococcus aureus. J Hosp Infect. 2005;61(4):277–82.
  3. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36(1):53–9.
  4. Bradley SF, Terpenning MS, Ramsey MA, Zarins LT, Jorgensen KA, Sottile WS, Schaberg DR, Kauffman CA. Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Ann Intern Med. 1991;115(6):417–22.
  5. Jernigan JA, Clemence MA, Stott GA, Titus MG, Alexander CH, Palumbo CM, Farr BM. Control of methicillin-resistant Staphylococcus aureus in a university hospital one decade later. Infect Control Hosp Epidemiol. 1995;16(12):686–96.
  6. Marschall J, Mühleman K. Duration of methicillin-resistant Staphylococcus aureus carriage, according to risk factors for acquisition. Infect Control Hosp Epidemiol. 2006;27(11):1206–12.
  7. Muder RR, Brennen C, Wagener MM, Vickers RM, Rihs JD, Handcock GA, et al. Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Ann Intern Med. 1991;114(2):107–12.
  8. Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis. 2004;39(6):776–82.
  9. EARSS (European Antimicrobial Resistance Surveillance System). Proportion of MRSA isolates in participating countries in 2008. Available at:
  10. Swiss Centre for Antibiotic resistance. Antibiotic resistance data 2008: Oxacillin-resistance of Staphylococcus aureus. Available at:
  11. Diekema DJ, Edmond MB. Look before you leap: active surveillance for multidrug-resistant organisms. Clin Infect Dis. 2007;44(8):1101–7.
  12. Bootsma MC, Diekmann O, Bonten MJ. Controlling methicillin-resistant Staphylococcus aureus: Quantifying the effects of interventions and rapid diagnostic testing. PNAS. 2006;103(14):5620–5.
  13. Wernitz MH, Swidsinski S, Weist K, Sohr D, Witte W, Franke KP, et al. Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. Clin Microbiol Infect. 2005;11(6):457–65.
  14. Peterson LR, Diekema DJ. To screen or not to screen for Methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2010;48(3):683–9.
  15. Wenzel RP, Bearman G, Edmond MB. Screening for MRSA: a flawed hospital infection control intervention. Infect Control Hosp Epidemiol. 2008;29:1012–8.
  16. Wertheim HF, Vos MC, Boelens HA, Voss A, Vandenbroucke-Grauls CM, Meester MH, et al. Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect. 2004;56(4):321–32.
  17. Jones G, Sutton JK, Aplin S, Browning D. How many patients do you need to screen for methicillin-resistant Staphylococcus aureus to find a positive? Results from a screening programme in a UK teaching hospital. Clin Microbiol Infect. 2010;16(S2):S46.
  18. Huang SS, Yokoe DS, Hinrichsen VL, Spurchise LS, Datta R, Miroshnik I, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2006;43(8):971–8.
  19. Harbarth S, Fankhauser C, Schrenzel J, Christenson J, Gervaz P, Bandiera-Clerc C, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA. 2008;299(10):1149–57.
  20. Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA. 2003;290(14):1899–905.
  21. Morgan DJ, Diekema DJ, Sepkowitz K, Perencevich EN. Adverse outcomes associated with contact precautions: a review of the literature. Am J Infect Control. 2009;37(2):85–93.
  22. Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Medley GF, et al. Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. Health Technol Assess. 2003;7(39):1–194.
  23. Mathews AA, Thomas M, Appalaraju B, Jayalakshmi J. Evaluation and comparison of tests to detect methicillin resistant S. aureus. Indian J Pathol Microbiol. 2010;53(1):79–82.
  24. Brown DF, Edwards DI, Hawkey PM, Morrison D, Ridgway GL, Towner KJ, Wren MW on behalf of the Joint Working Party of the British Society for Antimicrobial Chemotherapy, Hospital Infection Society and Infection Control Nurses Association. Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J Antimicrob Chemother. 2005;56(6):1000–8.
  25. Fleisch F, Oechslin EC, Gujer AR, Ritzler E, Imhof A, Ruef C, Reinhart WH. Transregional spread of a single clone of methicillin-resistant Staphylococcus aureus between groups of drug users in Switzerland. Infection. 2005;33(4):273–7.
  26. Edmond MB, Lyckholm L, Diekema DJ. Ethical implications of active surveillance cultures and contact precautions for controlling multidrug resistant organisms in the hospital setting. Public Health Ethics. 2008;1:235–45.
  27. Sax H, Allegranzi B, Chraiti MN, Boyce J, Larson E, Pittet D. The World Health Organization hand hygiene observation method. Am J Infect Control. 2009;37(10):827–34.
  28. Bühlmann M, Bögli-Stuber K, Droz S, Mühlemann K. Rapid screening for carriage of Methicillin-resistant Staphylococcus aureus by polymerase chain reaction and associated costs. J Clin Microbiol. 2008;46(7):2151–4.
  29. Swiss-Noso 12/1995; Band 2, Nummer 4. Methizillin-resistenter S. aureus: Aktuelle Situation und Bedeutung. Available at:
  30. Mertz D, Reno F, Periat N, Zimmerli M, Battegay M, Flückiger U, Widmer AF. Exclusive Staphylococcus aureus throat cariage. Arch Intern Med. 2009;169(2):172–8.
  31. Robicsek A, Beaumont JL, Paule SM, Hacek DM, Thomson RB Jr, Kaul KL, et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med. 2008;148(6):409–18.
  32. Weber SG, Huang SS, Oriola S, Huskins WC, Noskin GA, Harriman K, et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-reistant enterococci: position statement from the Joint SHEA and APIC Task Force. Infect Control Hosp Epidemiol. 2007;28(3):249–60.
  33. Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet. 2000;356:1307–12.